186 related articles for article (PubMed ID: 7683986)
41. Thermal injury during TUMT.
Sjödin JG; Eliasson T; Erlandson BE; Loyd D
Scand J Urol Nephrol; 1997 Dec; 31(6):561-4. PubMed ID: 9458516
[TBL] [Abstract][Full Text] [Related]
42. The predictive value of baseline variables in the treatment of benign prostatic hyperplasia using high-energy transurethral microwave thermotherapy.
d'Ancona FC; Francisca EA; Hendriks JC; Debruyne FM; de la Rosette JJ
Br J Urol; 1998 Dec; 82(6):808-13. PubMed ID: 9883216
[TBL] [Abstract][Full Text] [Related]
43. Transurethral microwave thermotherapy of the prostate without intravenous sedation: results of a single United States center using both low- and high-energy protocols. TJUH TUMT Study Group.
Rivas DA; Bagley D; Gomella LG; Hirsch IH; Hubert C; Lombardo S; McGinnis DE; Mulholland SG; Shenot PJ; Strup SE; Vasavada SP
Tech Urol; 2000 Dec; 6(4):282-7. PubMed ID: 11108567
[TBL] [Abstract][Full Text] [Related]
44. High-energy transurethral microwave thermotherapy: symptomatic vs urodynamic success.
Osman Y; Wadie B; El-Diasty T; Larson T
BJU Int; 2003 Mar; 91(4):365-70. PubMed ID: 12603416
[TBL] [Abstract][Full Text] [Related]
45. New technologies for the surgical management of symptomatic benign prostatic enlargement: tolerability and morbidity of high energy transurethral microwave thermotherapy.
Eliasson T; Wagrell L
Curr Opin Urol; 2000 Jan; 10(1):15-7. PubMed ID: 10650508
[TBL] [Abstract][Full Text] [Related]
46. [Transurethral microwave thermotherapy for benign prostatic hyperplasia].
Tokumitsu M; Mizunaga M; Kaneko S; Kitahara K; Kawakami N; Tsurukawa H; Noda T; Yachiku S
Nihon Hinyokika Gakkai Zasshi; 1997 Jul; 88(7):670-6. PubMed ID: 9267131
[TBL] [Abstract][Full Text] [Related]
47. The importance of the prostate weight in transurethral microwave thermotherapy.
Netto Júnior NR; de Lima ML; Claro Jde A; de Andrade EF
Arch Esp Urol; 1995 May; 48(4):413-7. PubMed ID: 7541194
[TBL] [Abstract][Full Text] [Related]
48. Transrectal ultrasonography to predict the clinical outcome of transurethral microwave thermotherapy in patients with benign prostatic hyperplasia.
Kurita Y; Ushiyama T; Suzuki K; Fujita K; Kawabe K
Int J Urol; 1996 Nov; 3(6):448-53. PubMed ID: 9170571
[TBL] [Abstract][Full Text] [Related]
49. High energy thermotherapy in the treatment of benign prostatic hyperplasia: results of the European Benign Prostatic Hyperplasia Study Group.
de la Rosette JJ; de Wildt MJ; Höfner K; Carter SS; Debruyne FM; Tubaro A
J Urol; 1996 Jul; 156(1):97-101; discussion 101-2. PubMed ID: 8648849
[TBL] [Abstract][Full Text] [Related]
50. Transurethral microwave thermotherapy vs transurethral resection for treating benign prostatic hyperplasia: a systematic review.
Hoffman RM; MacDonald R; Monga M; Wilt TJ
BJU Int; 2004 Nov; 94(7):1031-6. PubMed ID: 15541122
[TBL] [Abstract][Full Text] [Related]
51. Microwave treatment of BPH: still an option?
De La Rosette JJ
Arch Esp Urol; 1994 Nov; 47(9):889-94. PubMed ID: 7530945
[TBL] [Abstract][Full Text] [Related]
52. Transurethral microwave thermotherapy: how does it work?
Brehmer M; Baba S
J Endourol; 2000 Oct; 14(8):611-5. PubMed ID: 11083402
[TBL] [Abstract][Full Text] [Related]
53. Transurethral microwave thermotherapy for symptomatic benign prostatic hyperplasia: short-term experience with Prostcare.
Tsai YS; Lin JS; Tong YC; Tzai TS; Yang WH; Chang CC; Cheng HL; Lin YM; Jou YC
Urol Int; 2000; 65(2):89-94. PubMed ID: 11025430
[TBL] [Abstract][Full Text] [Related]
54. Efficacy and safety of the new high-energy 30-minute transurethral microwave thermotherapy: results of 1-year follow-up in a multicenter study.
de La Rosette JJ; Laguna MP; Pace G; Kortmann BB; Selvaggio O; Debruyne FM; Selvaggi FP
Tech Urol; 2000 Dec; 6(4):271-5. PubMed ID: 11108564
[TBL] [Abstract][Full Text] [Related]
55. Transurethral microwave thermotherapy: first experiences in Poland.
Jakubczyk T; Stoklosa A; Borkowski A; Habrat W; Dobrowolski Z
BJU Int; 2002 May; 89(7):767-70. PubMed ID: 11966643
[TBL] [Abstract][Full Text] [Related]
56. High-energy microwave thermotherapy in patients in urinary retention.
Naqvi SA; Rizvi SA; Hasan AS
J Endourol; 2000 Oct; 14(8):677-81. PubMed ID: 11083411
[TBL] [Abstract][Full Text] [Related]
57. Cost-effectiveness of new treatments for benign prostatic hyperplasia: results of a randomized trial comparing the short-term cost-effectiveness of transurethral interstitial laser coagulation of the prostate, transurethral microwave thermotherapy and standard transurethral resection or incision of the prostate.
Nørby B; Nielsen HV; Frimodt-Møller PC
Scand J Urol Nephrol; 2002; 36(4):286-95. PubMed ID: 12201922
[TBL] [Abstract][Full Text] [Related]
58. Clinical response to transurethral microwave thermotherapy is thermal dose dependent.
Devonec M; Ogden C; Perrin P; St Clair Carter S
Eur Urol; 1993; 23(2):267-74. PubMed ID: 7683985
[TBL] [Abstract][Full Text] [Related]
59. Three-year followup of patients treated with lower energy microwave thermotherapy.
de Wildt MJ; D'Ancona FC; Hubregtse M; Carter SS; Debruyne FM; de la Rosette JJ
J Urol; 1996 Dec; 156(6):1959-63. PubMed ID: 8911365
[TBL] [Abstract][Full Text] [Related]
60. Transurethral microwave thermotherapy for symptomatic benign prostatic hyperplasia: long-term durability with Prostcare.
Tsai YS; Lin JS; Tong YC; Tzai TS; Yang WH; Chang CC; Cheng HL; Lin YM; Jou YC
Eur Urol; 2001 Jun; 39(6):688-92; discussion 693-4. PubMed ID: 11464059
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
